Bristol-Myers Squibb Company (BMY) Management Presents at 2023 UBS BioPharma Conference (Transcript)

Bristol-Myers Squibb Company (NYSE:BMY) 2023 UBS BioPharma Conference Transcript November 8, 2023 8:00 AM ET Executives Lynelle Hoch - Head, Cell Therapy Analysts Trung Huynh - UBS Trung Huynh Okay. It’s 8 a.m. My name is Trung Huynh. I am one of the Therapeutics Analyst here at UBS. It’s my great pleasure to present to you guys, Bristol-Myers Squibb, for our first fireside session and conference. Today, we are talking about cell therapy for the next 45 minutes and for that we have got Lynelle Hoch, who is ...